key: cord-0725460-6o71tnwa authors: Keshavarz, Pedram; Yazdanpanah, Fereshteh; Azhdari, Sara; Kavandi, Hadiseh; Nikeghbal, Parisa; Bazyar, Amir; Rafiee, Faranak; Nejati, Seyed Faraz; Sadabad, Faranak Ebrahimian; Rezaei, Nima title: Coronavirus disease 2019 (COVID‐19): A systematic review of 133 Children that presented with Kawasaki‐like multisystem inflammatory syndrome date: 2021-05-24 journal: J Med Virol DOI: 10.1002/jmv.27067 sha: 556a9a3fc327f6206146dfa3ba5ec80070ea72de doc_id: 725460 cord_uid: 6o71tnwa Kawasaki‐like disease (KLD) and multisystem inflammatory syndrome in children (MIS‐C) are considered as challenges for pediatric patients under the age of 18 infected with coronavirus disease 2019 (COVID‐19). A systematic search was performed on July 2, 2020, and updated on December 1, 2020, to identify studies on KLD/MIS‐C associated with COVID‐19. The databases of Scopus, PubMed, Web of Science, Embase, and Scholar were searched. The hospitalized children with a presentation of Kawasaki disease (KD), KLD, MIS‐C, or inflammatory shock syndromes were included. A total number of 133 children in 45 studies were reviewed. A total of 74 (55.6%) cases had been admitted to pediatric intensive care units (PICUs). Also, 49 (36.8%) patients had required respiratory support, of whom 31 (23.3%) cases had required mechanical ventilation/intubation, 18 (13.5%) cases had required other oxygen therapies. In total, 79 (59.4%) cases had been discharged from hospitals, 3 (2.2%) had been readmitted, 9 (6.7%) had been hospitalized at the time of the study, and 9 (6.7%) patients had expired due to the severe heart failure, shock, brain infarction. Similar outcomes had not been reported in other patients. Approximately two‐thirds of the children with KLD associated with COVID‐19 had been admitted to PICUs, around one‐fourth of them had required mechanical ventilation/intubation, and even some of them had been required readmissions. Therefore, physicians are strongly recommended to monitor children that present with the characteristics of KD during the pandemic as they can be the dominant manifestations in children with COVID‐19. Since December 2019, the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from the family Coronaviridae causing coronavirus disease 2019 (COVID-19) emerged in Wuhan, China, and then became a global health challenge. This was the third epidemic of the large family Coronaviridae, which induced SARS and the Middle East respiratory syndrome at the beginning of the present century. 1, 2 The authors' knowledge of COVID-19 was thus based on two previous experiments in their early phases, that hyperinflammation caused by macrophage-activating syndrome and cytokine storm release (CSR) was involved in the pathogenesis of COVID-19. [3] [4] [5] [6] Initially, COVID-19 patients were identified with symptoms such as dry cough, fever, dyspnea, headache, weakness, and lethargy, which later appeared with gastrointestinal (GI), neurological, and cutaneous manifestations. 7, 8 Early on, it seemed that children were not the target groups and they were less likely to be affected, so there were a small number of reports on childhood illnesses. 9, 10 After a while, the surge of comparable reports of children attending In this respect, MIS-C refers to a hyperinflammatory systemic condition that shares numerous similar features of KD such as lymphadenopathy, diarrhea, elevated inflammatory biomarkers, prolonged fever, skin rash alongside some separate specifications like older onset, the predominance of abdominal symptoms, cases with left ventricular systolic dysfunction and acute heart failure (AHF). 11, 15 The present study was designed and implemented to demonstrate the relationship between severely ill cases with KD/ MIS-C and COVID-19. This study was conducted based on the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) reporting guidelines 16 on July 2, 2020, and updated on December 1, 2020, to identify the studies on KD/MIS-C associated with COVID-19. To this end, the relevant studies were searched using the databases of Scopus, PubMed (i.e., MEDLINE), Web of Science, Embase (Elsevier), and Scholar. The following search keywords were also used: "coronavirus," "COVID-19," "coronavirus and infection," "SARS-CoV-19," "2019 novel and coronavirus," "Kawasaki," "hyperinflammatory," "inflammatory syndrome," "Kawasaki-like," and "MIS-C." The keywords list utilized in the search is provided as a Supporting Information appendix. The PRISMA flow diagram of the study selection process is also illustrated in Figure 1 . The pediatric patients (0-≤18 years of age) with more than 1 day of subjective or measured fever (≥100.4°F/38°C) and hospital stay, that presented with at least KD, Kawasaki-like disease (KLD), MIS-C, or inflammatory shock syndromes, with the evidence of COVID-19, and with confirmed SARS-CoV-2 infection using nasopharyngeal RT-PCR or antibody (viz. serological) testing were included in this study. Moreover, irrelevant studies, conference abstracts, and duplicates were excluded. Two independent and blinded reviewers extracted the data and then performed crosschecking. A third reviewer also resolved the disagreements via consensus. Accordingly, the data were extracted: Regarding the quality assessment, two independent reviewers evaluated the risk of bias of the included cohort studies using the modified version of the Newcastle-Ottawa Scale, 19 and the National Institutes of Health Quality Assessment tool for case series/reports 20 (Tables S1 and S2 ). A total number of 69 studies were recognized in the initial search. After removing the duplicates and the irrelevant articles, 45 eligible studies including 6 cohort studies, 7 case series, 24 case reports, and 8 correspondences or letters to editors related to KLD/MIS-C associated with COVID-19 were included. As a whole, 133 children with the mean age of 9 ± 4.2 (age range: 4 months to 17 years old, interquartile range: 5.5-13 years old) with 82 (61.6%) male cases, 50 (37.5%) females, and one unknown gender were reviewed (Table 1) . Moreover, the type of disease mentioned in the studies was reported, and was then classified as KD in 46 With regard to the symptoms of patients, skin rash (n = 74, 55.6%) was the most common one followed by conjunctivitis (n = 65, 48.8%), and then lip and oral cavity changes in 43 (32.3%) patients, as summarized in Table 2 . Other KD clinical features such as GI symptoms (n = 97, 72.9%), hypotension (less than 90/50, n = 45, 33.8%), and pulmonary abnormalities (n = 35, 26.3%) were also present in these patients ( cases had been discharged from hospitals, 3 (2.2%) had been readmitted, 9 (6.7%) had been hospitalized at the time of the study, and 9 (6.7%) patients had expired. Likewise, the outcomes had not been reported in the rest of the patients (n = 33). In the initial analysis, the measured pooled mean (SE) for inflammatory cytokines such as C-reactive protein (CRP), erythrocyte F I G U R E 3 Cardiac MRI for four children with a clinical diagnosis of acute myocarditis in the setting of COVID-19-related Kawasaki-like symptoms. The top panel demonstrates minimal pericardial effusion on cine images. The second panel demonstrates increased T2-STIR signal intensity with average ratios between myocardium and muscle more than 2 in patient 2 (12-year-old male), patient 3 (11-year-old female), and patient 4 (6-year-old female). The third panel demonstrates abnormal native-T1 mapping, which was more than 1100 ms in patients 2, 3, and 4 and normal in patient 1 (8-year-old female). The bottom panel demonstrates absence of late gadolinium enhancement (LGE) in patients 2 and 3. Myocardial null times were recognized as too short in patient 4 but could not be repeated due to lack of further patient cooperation; however, a review of Look-Locker images and additional sequences revealed no LGE. Images obtained from Blondiaux et al. 18 In this systematic review, a total of 9 (6.7%) patients, mostly male dominance (66.6%) expired due to a wide variety of reasons. Severe heart failure and cardiac arrest played a predominant role in the mortality of these patients (n = 6). As patients Nos. As with the COVID-19 pandemic and its progress, the incidence of patients admitted with KD and other related diseases and symptoms such as KLD and MIS-C has increased, so there have been several reports from different countries. 21, 22 In this study, available evidence published updated globally until December 1st were systematically reviewed, and hyperinflammatory condition in children following COVID-19, threatening their lives, were reported. We found that more than half of children with KLD associated with COVID-19 had been admitted to PICUs, a quarter had required mechanical ventilation/intubation and even some of them had been required readmissions. Moreover, a 6.7% mortality rate was observed in children with KLD associated with COVID-19 that mostly due to severe heart failure, cardiac arrest, and refractory hypotension. Additionally, the male gender could be recognized as a poor prognostic factor with a fatality rate of two times higher than the female. Despite more than half a century since the initial reports of KD, no clear cause has been thus far identified, and no specific pathology has been recognized. 23 Considering the higher number of cases with KD after the outbreak of viral respiratory diseases, the most accepted hypothesis is the strange response of the immune system to With an overview of the gender distribution of the patients developing KD in association with COVID-19, male dominance had been apparent, which had the same order with KD alone. 30 Among the death reports in the reviewed cases, the ratio of male to female had been 2:1, so that the male gender could be recognized as a poor prognostic factor, which was consistent with mortality in adults with COVID-19, with the fatality rate of male two to three times higher than female. In adults, this effect had been hypothesized to be dependent on males with higher angiotensin-converting enzyme 2 expression, X chromosome immunological consequences, and hormonal differences 31, 32 ; So, ignoring the latter, the two other causes could be generalized to children. The study results revealed that GI manifestations were also prevalent in patients exhibiting KD associated with COVID-19, with a higher incidence rate than those in both non-COVID-19 KD and children with Also, this study revealed a higher mortality rate among patients with KD associated with COVID-19, compared to each of them alone, given that nine children had died and one had proceeded to brain death. 35, 36 Hyperinflammation state and augmented cytokine production in KD amidst the CSR associated with COVID-19, leading to several increased cytokines was further presumed causative in the progress of this condition that could make it more common in COVID-19; however, its inflammatory profile was different from that of COVID-19. The increased CRP and ferritin observed in the reviewed cases were supportive here. Nevertheless, the role of high troponin levels and hypotension in patients should not be missed, which could show serious cardiovascular diseases and their effects on higher mortality rates, insofar as inotropes had particular importance in the treatment of these patients following intravenous immunoglobulin and antibiotics ( Table 3 ). scarcity of cases in other parts of the world. The vast majority of demised patients in this review had circulation problems, and they suffered from heart failure and refractory hypotension despite aggressive therapy that didn′t respond to efforts. In most of them, the cytokine profile is different from whatever is generally seen in COVID-19 patients. Echocardiography of these patients mostly has various degrees of cardiac dysfunction, and in some cases, the arterial aneurysm was observed. It seems that their condition gets more critical when the cytokine storm begins to rise; while, in most of the above patients (death patients), the number of cytokines at the time of death is much higher than from the first examination. An equivocal point that needs further investigation is cytokine profile correlation with prognosis in these patients. However, we encounter a CSS in most patients who die; not all patients with high levels of inflammatory cytokines had complicated conditions. Although differences in the approach and treatment of patients can be one of the causes of this problem, due to the similarity of drug treatment and their focus on suppressing the immune system, other factors, including genetic variations, might be remarkable in this regard. One of the expired patients (No. 87) had a history of G6PD deficiency. The G6PD deficiency was introduced as a predisposing factor in the increasing incidence of COVID-19 because it plays a pivotal role in coronavirus viral gene expression and viral particle production. So, the action of this deficiency in the increase of mortality rate should also be investigated. 37 Among the limitations of this review study, at first, incomplete datasets for numerous properties, which made it impossible to present appropriate comparisons and conclusions. Second, the duration of followups was inadequate, leading to the omission of their long-term sequel. Thirdly, selection bias in the studies concerned in some countries was undeniable, as they might have been written in different languages rather than English. Considering the studies were slightly heterogeneous and their information was not comparable in some characteristics, multidisciplinary research in this field is recommended to shed light on the obscure dimensions of this condition. This systematic review established that approximately two-thirds of children with KLD associated with COVID-19 had been admitted to PICUs. Moreover, around one-fourth of them had required mechanical ventilation/intubation and even some of them had required readmissions. Therefore, pediatricians and physicians are strongly recommended to monitor children that present with fever, GI symptoms, and other characteristics of KD during the pandemic as they can be the dominant manifestations in children with COVID-19. Accordingly, irreversible complications can be prevented through early diagnosis and treatment. Clinical features of patients infected with 2019 novel coronavirus in Wuhan Coronavirus disease 2019 (COVID-19): a systematic review of pregnancy and the possibility of vertical transmission The immune system and COVID-19: friend or foe? The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis The immune system as a target for therapy of SARS-CoV-2: a systematic review of the current immunotherapies for COVID-19 Coronavirus disease 2019 (COVID-19) in molecular imaging: a systematic review of incidental detection of SARS-CoV-2 pneumonia on PET studies Cutaneous manifestations in COVID-19: a first perspective Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study COVID-19 in children: an epidemiology study from China COVID-19 in 7780 pediatric patients: a systematic review Multisystem inflammatory syndrome in children during the COVID-19 pandemic: a case series Multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2 infection: a multi-institutional study from New York City Ischemic gastrointestinal complications of COVID-19: a systematic review on imaging presentation Characterisation of COVID-19 pandemic in paediatric age group: a systematic review health alert# 13: pediatric multi-system inflammatory syndrome potentially associated with COVID-19. NYC Health Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Septic shock presentation in adolescents with COVID-19 Cardiac MRI of children with multisystem inflammatory syndrome (MIS-C) associated with COVID-19: case series Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle-Ottawa scale and the RTI item bank Study quality assessment tools An outbreak of severe Kawasakilike disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study COVID-19 and Kawasaki disease: novel virus and novel case Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association Concurrent respiratory viruses and Kawasaki disease Kawasaki disease: insights into pathogenesis and approaches to treatment Viral infections associated with Kawasaki disease Human coronavirus NL63 is not detected in the respiratory tracts of children with acute Kawasaki disease Lack of association between infection with a novel human coronavirus (HCoV), HCoV-NH, and Kawasaki disease in Taiwan Association between a novel human coronavirus and Kawasaki disease Kawasaki disease: epidemiology and the lessons from it Sexderived attributes contributing to SARS-CoV-2 mortality COVID-19 infection: origin, transmission, and characteristics of human coronaviruses Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and metaanalysis The immunology of multisystem inflammatory syndrome in children with COVID-19 Mortality rates for patients with a history of Kawasaki disease in Japan Estimates of the severity of coronavirus disease 2019: a model-based analysis Glucose-6-phosphate dehydrogenase deficiency enhances human coronavirus 229E infection Pediatric patients with COVID-19 presented as multi-system inflammatory syndrome Cepinskas G Inflammation and Endothelial Injury Profiling in COVID-19 Pediatric Multi-system Inflammatory Syndrome Introductory histopathologic findings may shed light on COVID19 pediatric hyperinflammatory shock syndrome Multisystem inflammatory syndrome with features of atypical Kawasaki disease during COVID-19 pandemic Neurological manifestations of pediatric multi-system inflammatory syndrome potentially associated with COVID-19. Child's Nervous Sys Toxic shock-like syndrome and COVID-19: a case report of multisystem inflammatory syndrome in children (MIS-C) A child with a severe multi-system inflammatory syndrome following an asymptomatic COVID-19 infection: a novel management for a new disease Is Novel Corona Virus Truly a Trigger for Kawasaki Disease in Infants?-Reporting the First Asian Case Dermatological manifestation of pediatrics multisystem inflammatory syndrome associated with COVID-19 in a 3-year-old girl Incomplete Kawasaki disease in a child with Covid-19 SARS-CoV-2 infection in two pediatric patients with immune cytopenias: a single institution experience during the pandemic Kawasaki disease features and myocarditis in a patient with COVID-19 COVID-19 multisystem inflammatory syndrome in three teenagers with confirmed SARS-CoV-2 infection Cardiac dysfunction and shock in pediatric patients with COVID-19 SARS-CoV-2-induced Kawasakilike hyperinflammatory syndrome: a novel COVID phenotype in children Multisystem inflammatory syndrome in children (MIS-C) related to COVID-19: a New York City experience COVID-19-associated pediatric multisystem inflammatory syndrome Novel paediatric presentation of COVID-19 with ARDS and cytokine storm syndrome without respiratory symptoms Pediatric life-threatening coronavirus disease 2019 with myocarditis Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children Severe COVID-19 in children and young adults in the Washington, DC metropolitan region Hyperinflammatory syndrome in a child with COVID-19 treated successfully with intravenous immunoglobulin and tocilizumab Hyperinflammatory shock in children during COVID-19 pandemic Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department Kawasaki-like disease in children with COVID-19 Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: first case from Iran. J Paediatr Child Health A case of pediatric multisystem inflammatory syndrome temporally associated with COVID-19 in South Dakota Special dermatological presentation of paediatric multisystem inflammatory syndrome related to COVID-19: erythema multiforme Case report: pediatric patient with COVID-19 and multisystem inflammatory syndrome in children Multisystem inflammatory syndrome in children temporally related to COVID-19: a case report From Saudi Arabia Atypical case of COVID-19 associated Kawasaki Disease in an eight-year-old Pakistani Boy A case of multisystem inflammatory syndrome in children mimicking acute appendicitis in a COVID-19 pandemic area Kawasaki Disease-like features in 10 pediatric COVID-19 cases: a retrospective study Multisystem inflammatory syndrome in children, the real disease of COVID-19 in pediatrics-a multicenter case series From Al-Ahsa, Saudi Arabia Incomplete Kawasaki disease as presentation of COVID-19 infection in an infant: a case report Multisystem inflammatory syndrome in children related to COVID-19: the first case in Korea Multisystem inflammatory syndrome associated with coronavirus disease in children: a multicentered study in Clinical characteristics of 10 children with a pediatric inflammatory multisystem syndrome associated with COVID-19 in Iran Multisystem inflammatory syndrome in children during the COVID-19 pandemic: a case report on managing the hyperinflammation Multisystem inflammatory syndrome in children (MIS-C) in an Adolescent that developed coronary aneurysms: a case report and review of the literature The authors declare that there are no conflict of interests. The authors would like to thank Dr. Cecilia Dallan and Dr. Eleonore Blondiaux for providing the images and figures for this study and also, thank publisher holder of Radiology (RSNA) and Elsevier for granting permission to use the images. investigation, data curation, writing-review and editing. Nima Rezaei:writing-review and editing, conceptualization, investigation. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. http://orcid.org/0000-0002-0221-346XNima Rezaei http://orcid.org/0000-0002-3836-1827